All episodes
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?
Management of Rare Kidney Tumors
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?
NanoString Treatment for Kidney Cancer
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
How is the Heng Criteria Applied to Kidney Cancer Patients?
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?
What is PD1 and PDL1 in Kidney Cancer?
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope
No Clear Answer for Non-Clear Cell Kidney Cancer
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer
Treating Newly Diagnosed Kidney Cancer
MET-Amplified Lung Cancer: A New Target for XALKORI?
The Hottest Thing in Late Stage Kidney Cancer
CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer
The Promise of PD1 Inhibitors in Kidney Cancer
FGFR and Its Role in Treating Squamous Cell Lung Cancer
AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer
What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer?
What Is Non-Clear Cell Kidney Cancer?
The Promise of Immunotherapy in Lung Cancer
Does Gilotrif Help EGFR Positive Lung Cancer Patients?
Is Progression-Free Survival Meaningful?
DDR2 Mutations in Squamous Cell Lung Cancer
Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?
What is FGFR, and Could It Be a Valuable Target for Patients with Lung Cancer?
How Do We Make EGFR Inhibitors Work Better for Patients
TH 302: New Drug May Make Tumors Less Resistant to Treatment
Should We Do Broad Sequencing of All Lung Tumors?
How Do the New ALK Inhibitor Drugs Compare to Xalkori (Crizotinib) for ALK+ Lung Cancer Patients?
Why Are Non-Mutated EGFR Genes Called "Wild Type?"
Teaching the Immune System to Attack Lung Cancer Tumors
Advice for Lung Cancer Patients: Know Thy Cancer
Is It Necessary for Early Stage Lung Cancer Patients to Get Molecular Testing for Their Tumors?
Treating EGFR Patients After Tarceva Stops Working
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer?
An Update on ECOG 1505: Will Avastin (Bevacizumab) Become Standard Treatment for Early Stage Lung Cancer Patients?
Targeted Treatment for Lung Cancer After Progression
Can Vaccines Fight Lung Cancer?
CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients
Why Do We Call Them "Small Cell Lung Cancer" and "Non-Small Cell Lung Cancer"?
Targeting the RAF Pathway in Lung Cancer
Is It Possible to Test Lung Tumors Without Doing a Biopsy?
What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?
New Insights into Small Cell Lung Cancer
In What Clinical Setting Should Immunotherapies Be Developed?
Maintenance Therapy in Small Cell Lung Cancer
LDE225 and Small Cell Lung Cancer
Is There a Silver Bullet for Small Cell Lung Cancer?
Advice for Newly Diagnosed Small Cell Lung Cancer Patients
PARP Inhibitors in Small Cell Lung Cancer